After a five-day climb last week that saw a 2.61% rise, the BEL 20 index continued its upward trend, gaining a further 0.70% on Monday to reach 4,116.86 points.
Gains were registered by 12 of its constituents, against a backdrop of negative figures from its European peers.
The index’s best performers included pharmaceutical company UCB, which surged 3.52% to €157.40, and immunology concern arGEN-X, up 1.71% at €459.10.
Negative contributors included AB InBev, Umicore and Melexis, which registered declines of 1.92%, 0.31% and 1.70% respectively.
Galapagos climbed slightly by 0.64% to reach €25.30, while Solvay and Syensqo dipped marginally by 0.24% and 0.17% respectively.
The real estate stocks of Aedifica and Cofinimmo performed quite well, up by 0.92% and 1.60% respectively, while D’Ieteren and Elia appreciated by 0.57% and 0.94%.
Beyond the BEL 20, Tubize and Exmar surged 3.4%, while Euronav rose 1.6%. In contrast, Econocom and Unifiedpost both saw drops of 3.2%.
Biosenic and Nyxoah faced negative dips of 5.1% and 2% respectively, though Sequana Medical rebounded by 7.1%.
As at 4:30 PM, the Euro traded at 1.0805 against the US dollar, down from 1.0855 last Friday. Gold bullion was trading around €71,095, up by €490.
